CY1114069T1 - Νουκλεϊνικο οξυ και αντιστοιχη πρωτεϊνη με τιτλο 161p2f10b χρησιμα στη θεραπεια και ανιχνευση καρκινου - Google Patents
Νουκλεϊνικο οξυ και αντιστοιχη πρωτεϊνη με τιτλο 161p2f10b χρησιμα στη θεραπεια και ανιχνευση καρκινουInfo
- Publication number
- CY1114069T1 CY1114069T1 CY20131100233T CY131100233T CY1114069T1 CY 1114069 T1 CY1114069 T1 CY 1114069T1 CY 20131100233 T CY20131100233 T CY 20131100233T CY 131100233 T CY131100233 T CY 131100233T CY 1114069 T1 CY1114069 T1 CY 1114069T1
- Authority
- CY
- Cyprus
- Prior art keywords
- 161p2f10b
- title
- detection
- cancer treatment
- nuclear acid
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 201000011510 cancer Diseases 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- 239000012634 fragment Substances 0.000 abstract 2
- 230000024932 T cell mediated immunity Effects 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 230000028996 humoral immune response Effects 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Περιγράφονται νέο γονίδιο το 0161P2F10B (που ορίζεται επίσης ως 161P2F10B) και η κωδικοποιημένη πρωτεΐνη του, και παραλλαγές αυτών, όπου το 161P2F10B επιδεικνύει ιστοειδική έκφραση σε κανονικό ενήλικα ιστό, και εκφράζεται κατά παρέκκλιση τους καρκίνους που καταγράφονται στον Πίνακα I. Συνεπώς, το 161P2F10B παρέχει έναν διαγνωστικό, προγνωστικό, προφυλακτικό ή/και θεραπευτικό στόχο για τον καρκίνο. Το γονίδιο 161P2F10B ή κλάσμα αυτού, ή η κωδικοποιημένη πρωτεΐνη του, ή παραλλαγές αυτών, ή ένα κλάσμα αυτών, μπορούν να χρησιμοποιηθούν για να προκαλέσουν χυμική ή κυτταρική ανοσοαπόκριση, με τα αντισώματα ή Τ κύτταρα που είναι αντιδραστικά με το 161P2F10B να μπορούν να χρησιμοποιηθούν στην ενεργή ή παθητική ανοσοποίηση.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/005,480 US20030191073A1 (en) | 2001-11-07 | 2001-11-07 | Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
US10/062,109 US7067130B2 (en) | 2001-11-07 | 2002-01-31 | Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
EP02797088A EP1537140B1 (en) | 2001-11-07 | 2002-11-07 | Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1114069T1 true CY1114069T1 (el) | 2016-07-27 |
Family
ID=27803545
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20131100233T CY1114069T1 (el) | 2001-11-07 | 2013-03-20 | Νουκλεϊνικο οξυ και αντιστοιχη πρωτεϊνη με τιτλο 161p2f10b χρησιμα στη θεραπεια και ανιχνευση καρκινου |
Country Status (9)
Country | Link |
---|---|
US (4) | US20030191073A1 (el) |
EP (1) | EP2302041A1 (el) |
JP (1) | JP4299872B2 (el) |
AU (1) | AU2010226920B2 (el) |
CY (1) | CY1114069T1 (el) |
DK (1) | DK1537140T3 (el) |
ES (1) | ES2406431T3 (el) |
IL (3) | IL161268A (el) |
PT (1) | PT1537140E (el) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030191073A1 (en) * | 2001-11-07 | 2003-10-09 | Challita-Eid Pia M. | Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
US7226594B2 (en) * | 2001-11-07 | 2007-06-05 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
US8350009B2 (en) * | 2005-03-31 | 2013-01-08 | Agensys, Inc. | Antibodies and related molecules that bind to 161P2F10B proteins |
EP2444099A1 (en) | 2005-03-31 | 2012-04-25 | Agensys, Inc. | Antibodies and related molecules that bind to 161P2F10B proteins |
US20070031876A1 (en) * | 2005-08-08 | 2007-02-08 | Hsueh-Kung Lin | Methods of providing gene expression profiles for metastatic cancer phenotypes utilizing differentially expressed transcripts associated with circulating tumor cells |
WO2007129223A2 (en) * | 2006-01-23 | 2007-11-15 | Ad Group | Systems and methods for distributing emergency messages |
ES2328776B1 (es) * | 2007-11-19 | 2010-07-06 | Proyecto De Biomedicina Cima S.L. | Peptidos con capacidad para unirse a escurfina y aplicaciones. |
JP6046494B2 (ja) * | 2010-02-08 | 2016-12-14 | アジェンシス,インコーポレイテッド | 161p2f10bタンパク質に結合する抗体薬物コンジュゲート(adc) |
US8449512B2 (en) | 2010-04-09 | 2013-05-28 | Davinci Biomedical Research Products Inc. | Stoma stabilitating device and method |
US20140114581A1 (en) * | 2011-02-28 | 2014-04-24 | Carnegie Mellon University | Using game theory in identifying compounds that bind to targets |
GB201505585D0 (en) * | 2015-03-31 | 2015-05-13 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carinoma (RCC) and other cancers |
TWI772927B (zh) * | 2015-03-31 | 2022-08-01 | 德商英麥提克生物技術股份有限公司 | 用於腎細胞癌(rcc)免疫治療的新型肽和肽組合物和支架 |
EP4079322A1 (en) * | 2015-11-20 | 2022-10-26 | Yale University | Compositions for treating ectopic calcification disorders, and methods using same |
JP2019532915A (ja) | 2016-08-05 | 2019-11-14 | イエール ユニバーシティ | 小児鎌状赤血球貧血患者における脳卒中予防のための組成物および方法 |
Family Cites Families (96)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
US4722848A (en) | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
US4870009A (en) | 1982-11-22 | 1989-09-26 | The Salk Institute For Biological Studies | Method of obtaining gene product through the generation of transgenic animals |
US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
US4736866B1 (en) | 1984-06-22 | 1988-04-12 | Transgenic non-human mammals | |
US5430136A (en) | 1984-10-16 | 1995-07-04 | Chiron Corporation | Oligonucleotides having selectably cleavable and/or abasic sites |
US5019369A (en) | 1984-10-22 | 1991-05-28 | Vestar, Inc. | Method of targeting tumors in humans |
US5506337A (en) | 1985-03-15 | 1996-04-09 | Antivirals Inc. | Morpholino-subunit combinatorial library and method |
DE3675588D1 (de) | 1985-06-19 | 1990-12-20 | Ajinomoto Kk | Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist. |
US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
US5001225A (en) | 1986-12-08 | 1991-03-19 | Georgetown University | Monoclonal antibodies to a pan-malarial antigen |
US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
US5359100A (en) | 1987-10-15 | 1994-10-25 | Chiron Corporation | Bifunctional blocked phosphoramidites useful in making nucleic acid mutimers |
US5124246A (en) | 1987-10-15 | 1992-06-23 | Chiron Corporation | Nucleic acid multimers and amplified nucleic acid hybridization assays using same |
GB8724885D0 (en) | 1987-10-23 | 1987-11-25 | Binns M M | Fowlpox virus promotors |
US5254678A (en) | 1987-12-15 | 1993-10-19 | Gene Shears Pty. Limited | Ribozymes |
US5010175A (en) | 1988-05-02 | 1991-04-23 | The Regents Of The University Of California | General method for producing and selecting peptides with specific properties |
CA1340323C (en) | 1988-09-20 | 1999-01-19 | Arnold E. Hampel | Rna catalyst for cleaving specific rna sequences |
US5225538A (en) | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
WO1990010448A2 (en) | 1989-03-07 | 1990-09-20 | Genentech, Inc. | Covalent conjugates of lipid and oligonucleotide |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
WO1991004753A1 (en) | 1989-10-02 | 1991-04-18 | Cetus Corporation | Conjugates of antisense oligonucleotides and therapeutic uses thereof |
US5208020A (en) | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
EP0452457B1 (en) | 1989-11-03 | 1997-08-20 | Vanderbilt University | Method of in vivo delivery of functioning foreign genes |
US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
US6673986B1 (en) | 1990-01-12 | 2004-01-06 | Abgenix, Inc. | Generation of xenogeneic antibodies |
DE69133566T2 (de) | 1990-01-12 | 2007-12-06 | Amgen Fremont Inc. | Bildung von xenogenen Antikörpern |
US5279833A (en) | 1990-04-04 | 1994-01-18 | Yale University | Liposomal transfection of nucleic acids into animal cells |
US5204253A (en) | 1990-05-29 | 1993-04-20 | E. I. Du Pont De Nemours And Company | Method and apparatus for introducing biological substances into living cells |
IE66205B1 (en) | 1990-06-14 | 1995-12-13 | Paul A Bartlett | Polypeptide analogs |
US5723286A (en) | 1990-06-20 | 1998-03-03 | Affymax Technologies N.V. | Peptide library and screening systems |
DE69132771T2 (de) | 1990-06-27 | 2002-08-01 | Princeton University Princeton | Sonden für die detektion der p53 mutante |
US5650489A (en) | 1990-07-02 | 1997-07-22 | The Arizona Board Of Regents | Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
SE9002480D0 (sv) | 1990-07-23 | 1990-07-23 | Hans Lilja | Assay of free and complexed prostate-specific antigen |
US5733731A (en) | 1991-10-16 | 1998-03-31 | Affymax Technologies N.V. | Peptide library and screening method |
US5573905A (en) | 1992-03-30 | 1996-11-12 | The Scripps Research Institute | Encoded combinatorial chemical libraries |
US5541061A (en) | 1992-04-29 | 1996-07-30 | Affymax Technologies N.V. | Methods for screening factorial chemical libraries |
EP0646178A1 (en) | 1992-06-04 | 1995-04-05 | The Regents Of The University Of California | expression cassette with regularoty regions functional in the mammmlian host |
CA2141960A1 (en) | 1992-08-07 | 1994-02-17 | Ralph T. Kubo | Hla binding peptides and their uses |
US5288514A (en) | 1992-09-14 | 1994-02-22 | The Regents Of The University Of California | Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support |
EP0604289B1 (fr) | 1992-12-17 | 1997-09-24 | Valeo Systemes D'essuyage | Procédé et dispositif d'alimentation d'un moteur électrique d'entrainement d'un bras d'essuie-glace de véhicule automobile |
US5576220A (en) | 1993-02-19 | 1996-11-19 | Arris Pharmaceutical Corporation | Thin film HPMP matrix systems and methods for constructing and displaying ligands |
DE69435292D1 (de) | 1993-03-05 | 2010-06-17 | Epimmune Inc | Verfahren zur herstellung von immunogenen hla-a2.1-bindenden peptiden |
EP0702716A4 (en) | 1993-05-17 | 1999-05-26 | Univ California | GENTHERAPY FOR HIV INFECTION AND AIDS WITH THE AID OF RIBOZYMS |
US5837501A (en) | 1993-07-09 | 1998-11-17 | Akzo Nobel N.V. | Nucleic acid quantitation by co-amplification of target with multiple internal controls |
US5679647A (en) | 1993-08-26 | 1997-10-21 | The Regents Of The University Of California | Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
US5804566A (en) | 1993-08-26 | 1998-09-08 | The Regents Of The University Of California | Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides |
JP3926839B2 (ja) | 1993-09-14 | 2007-06-06 | エピミューン,インコーポレイティド | 万能dr−結合性ペプチドを用いる免疫応答の改変 |
US5681697A (en) | 1993-12-08 | 1997-10-28 | Chiron Corporation | Solution phase nucleic acid sandwich assays having reduced background noise and kits therefor |
CH686982A5 (fr) | 1993-12-16 | 1996-08-15 | Maurice Stroun | Méthode pour le diagnostic de cancers. |
US5519134A (en) | 1994-01-11 | 1996-05-21 | Isis Pharmaceuticals, Inc. | Pyrrolidine-containing monomers and oligomers |
US5593853A (en) | 1994-02-09 | 1997-01-14 | Martek Corporation | Generation and screening of synthetic drug libraries |
US5539083A (en) | 1994-02-23 | 1996-07-23 | Isis Pharmaceuticals, Inc. | Peptide nucleic acid combinatorial libraries and improved methods of synthesis |
US5739118A (en) | 1994-04-01 | 1998-04-14 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
US5525735A (en) | 1994-06-22 | 1996-06-11 | Affymax Technologies Nv | Methods for synthesizing diverse collections of pyrrolidine compounds |
US5549974A (en) | 1994-06-23 | 1996-08-27 | Affymax Technologies Nv | Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof |
EP1405911A1 (en) | 1994-07-20 | 2004-04-07 | The General Hospital Corporation | Interaction trap systems for detecting protein interactions |
US5597909A (en) | 1994-08-25 | 1997-01-28 | Chiron Corporation | Polynucleotide reagents containing modified deoxyribose moieties, and associated methods of synthesis and use |
US5580731A (en) | 1994-08-25 | 1996-12-03 | Chiron Corporation | N-4 modified pyrimidine deoxynucleotides and oligonucleotide probes synthesized therewith |
US5681702A (en) | 1994-08-30 | 1997-10-28 | Chiron Corporation | Reduction of nonspecific hybridization by using novel base-pairing schemes |
US5919652A (en) | 1994-11-09 | 1999-07-06 | The Regents Of The University Of California | Nucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereof |
US5736524A (en) | 1994-11-14 | 1998-04-07 | Merck & Co.,. Inc. | Polynucleotide tuberculosis vaccine |
US5962428A (en) | 1995-03-30 | 1999-10-05 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
AU716893B2 (en) | 1995-04-11 | 2000-03-09 | General Hospital Corporation, The | Reverse two-hybrid systems |
US5922687A (en) | 1995-05-04 | 1999-07-13 | Board Of Trustees Of The Leland Stanford Junior University | Intracellular delivery of nucleic acids using pressure |
US5585639A (en) | 1995-07-27 | 1996-12-17 | Hewlett-Packard Company | Optical scanning apparatus |
US5569588A (en) | 1995-08-09 | 1996-10-29 | The Regents Of The University Of California | Methods for drug screening |
CU22559A1 (es) | 1996-01-17 | 1999-05-03 | Ct Ingenieria Genetica Biotech | Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión |
CA2248657A1 (en) | 1996-03-11 | 1997-09-18 | Epimmune Inc. | Peptides with increased binding affinity for hla molecules |
DE69715621T2 (de) | 1996-04-26 | 2003-05-22 | Massachusetts Inst Technology | Drei hybriden screening test |
US6294378B1 (en) | 1996-07-26 | 2001-09-25 | Sloan-Kettering Institute For Cancer Research | Method and reagents for genetic immunization |
US5925523A (en) | 1996-08-23 | 1999-07-20 | President & Fellows Of Harvard College | Intraction trap assay, reagents and uses thereof |
DE69738077T2 (de) | 1996-10-15 | 2008-05-21 | The Regents Of The University Of California, Oakland | Tiermodelle für die menschliche prostatakrebsfortschreitung |
US6365797B1 (en) | 1997-10-15 | 2002-04-02 | The Regents Of The University Of California | Mice models of human prostate cancer progression |
US5846722A (en) | 1996-10-16 | 1998-12-08 | Terrapin Technologies, Inc. | System to detect small molecule/peptide interaction |
US5840501A (en) | 1996-10-25 | 1998-11-24 | Bayer Corporation | Determination of cPSA |
CA2722378C (en) | 1996-12-03 | 2015-02-03 | Amgen Fremont Inc. | Human antibodies that bind tnf.alpha. |
US6323321B1 (en) * | 1997-03-05 | 2001-11-27 | Eberhard-Karls-Universitat Tubingen Universitatsklinikum | Antibody 97A6 |
CA2332150A1 (en) | 1998-05-15 | 1999-11-25 | Rami Skaliter | Mechanical stress induced genes, expression products therefrom, and uses thereof |
AU1208100A (en) | 1998-10-15 | 2000-05-01 | Genetics Institute Inc. | Secreted expressed sequence tags (sests) |
US20020137139A1 (en) | 1999-01-12 | 2002-09-26 | Byatt John C | Nucleic acid and other molecules associated with lactation and muscle and fat deposition |
US6342221B1 (en) * | 1999-04-28 | 2002-01-29 | Board Of Regents, The University Of Texas System | Antibody conjugate compositions for selectively inhibiting VEGF |
WO2001057252A2 (en) | 2000-02-04 | 2001-08-09 | Aeomica, Inc. | Methods and apparatus for high-throughput detection and characterization of alternatively spliced genes |
WO2001060860A2 (en) | 2000-02-17 | 2001-08-23 | Millennium Predictive Medicine, Inc. | Genes differentially expressed in human prostate cancer and their use |
US6436703B1 (en) | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
CA2442820A1 (en) | 2001-03-29 | 2002-10-10 | Van Andel Institute | Microarray gene expression profiling in clear cell renal cell carcinoma: prognosis and drug target identification |
US20030191073A1 (en) | 2001-11-07 | 2003-10-09 | Challita-Eid Pia M. | Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
WO2003004514A1 (en) | 2001-07-06 | 2003-01-16 | Origene Technologies, Inc | Small intestine and colon genes |
AU2002324700A1 (en) | 2001-08-14 | 2003-03-03 | Bayer Ag | Nucleic acid and amino acid sequences involved in pain |
US7226594B2 (en) * | 2001-11-07 | 2007-06-05 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
US20060272211A1 (en) * | 2005-06-03 | 2006-12-07 | Motelow Jerome L | Easy tilt and drain flower pot ("ET & DFP") |
CN104010774B (zh) | 2011-09-15 | 2017-10-13 | 康富真信息技术股份有限公司 | 用于自动生成机器人程序的系统和方法 |
-
2001
- 2001-11-07 US US10/005,480 patent/US20030191073A1/en not_active Abandoned
-
2002
- 2002-01-31 US US10/062,109 patent/US7067130B2/en not_active Expired - Lifetime
- 2002-11-07 DK DK02797088.8T patent/DK1537140T3/da active
- 2002-11-07 PT PT27970888T patent/PT1537140E/pt unknown
- 2002-11-07 EP EP10012125A patent/EP2302041A1/en not_active Withdrawn
- 2002-11-07 ES ES02797088T patent/ES2406431T3/es not_active Expired - Lifetime
-
2004
- 2004-04-04 IL IL161268A patent/IL161268A/en active IP Right Grant
- 2004-06-02 US US10/859,643 patent/US7279556B2/en not_active Expired - Lifetime
- 2004-06-02 US US10/860,769 patent/US7405290B2/en not_active Expired - Lifetime
-
2008
- 2008-02-25 JP JP2008043368A patent/JP4299872B2/ja not_active Expired - Lifetime
-
2010
- 2010-07-06 IL IL206832A patent/IL206832A/en active IP Right Grant
- 2010-10-01 AU AU2010226920A patent/AU2010226920B2/en not_active Expired
-
2012
- 2012-01-01 IL IL217317A patent/IL217317A/en active IP Right Grant
-
2013
- 2013-03-20 CY CY20131100233T patent/CY1114069T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU2010226920B2 (en) | 2012-01-19 |
DK1537140T3 (da) | 2013-04-15 |
US20030191073A1 (en) | 2003-10-09 |
US20070004913A1 (en) | 2007-01-04 |
IL217317A0 (en) | 2012-02-29 |
JP4299872B2 (ja) | 2009-07-22 |
JP2008188015A (ja) | 2008-08-21 |
IL217317A (en) | 2013-12-31 |
US20030165505A1 (en) | 2003-09-04 |
EP2302041A1 (en) | 2011-03-30 |
IL206832A (en) | 2012-05-31 |
US7279556B2 (en) | 2007-10-09 |
AU2010226920A1 (en) | 2010-10-28 |
US7067130B2 (en) | 2006-06-27 |
IL206832A0 (en) | 2010-12-30 |
US7405290B2 (en) | 2008-07-29 |
IL161268A (en) | 2012-04-30 |
US20060002993A1 (en) | 2006-01-05 |
ES2406431T3 (es) | 2013-06-07 |
PT1537140E (pt) | 2013-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1114069T1 (el) | Νουκλεϊνικο οξυ και αντιστοιχη πρωτεϊνη με τιτλο 161p2f10b χρησιμα στη θεραπεια και ανιχνευση καρκινου | |
DK1629088T3 (da) | Varianter af prostatastamcelleantigen (psca) og undersekvenser deraf | |
CY1113247T1 (el) | Νουκλεϊνικα οξεα με τιτλο 273ρ4β7 και η χρηση τους στην ανιχνευση καρκινου | |
CY1113064T1 (el) | Νουκλεϊνικο οξυ και αντιστοιχη πρωτεϊνη με τιτλο 184ρ1ε2 χρησιμα στη θεραπεια και ανιχνευση καρκινου | |
WO2003022995A3 (en) | Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer | |
WO2003040340A3 (en) | Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer | |
IL181218A0 (en) | Nucleic acids and corresponding 58p1d12 proteins for use in the detection and treatment of cancer | |
WO2004098515A3 (en) | Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer | |
WO2002072785A3 (en) | Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer | |
WO2002060953A3 (en) | Nucleic acid and encoded zinc transporter protein entitled 108p5h8 useful in treatment and detection of cancer | |
WO2002083928A3 (en) | Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer | |
WO2006055004A8 (en) | Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer | |
WO2002092842A3 (en) | Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer | |
MXPA05002520A (es) | Secuencia de acido nucleico 98p4b6 asociada con el cancer. | |
CY1112424T1 (el) | Πυρηνικο οξυ και αντιστοιχη πρωτεϊνη με τιτλο 238ρ1β2 χρησιμα στην αγωγη και ανιχνευση του καρκινου | |
WO2002095009A3 (en) | Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer | |
CY1116795T1 (el) | Αντισωματα και σχετικα μορια που δεσμευονται στις πρωτεϊνες toy psca | |
CY1108768T1 (el) | Νουκλεϊνικο οξυ και αντιστοιχη πρωτεϊνη ονομαζομενη 121ρ2α3 χρησιμη για την αγωγη και την ανιχνευση του καρκινου | |
CY1113332T1 (el) | Νουκλεϊκα οξεα και αντιστοιχες πρωτεϊνες με ονομασια 191p4d12(b) χρησιμα στην αγωγη και ανιχνευση καρκινου | |
CY1114674T1 (el) | Αντισωματα και σχετικα μορια που προσδενονται σε 24p4c12 πρωτεϊνες |